Advanced Heart Failure and Transplant Cardiology · Boston, MA
NPI
1659632701
Since 2012
Specialty
Advanced Heart Failure and Transplant Cardiology
Code 207RA0001X
Group practices
5
Medicare group memberships
Hospitals
3
Hospital affiliations
330 Brookline Ave
Boston, MA, 02215
Phone (617) 667-7000
Groups this clinician bills Medicare through
Medicare paid, 2024
$50K
611 services
Medicare patients, 2024
170
Average age 71
Drug cost, 2024
$6.9M
1,575 prescriptions
Company payments, 2025
$19K
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jan M Griffin was code 99215 (office e&m - established), 159 times for 95 patients. In total Jan M Griffin billed 611 services in 19 codes, and Medicare paid $50K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 159 | 95 | $96.69 | $15K |
| 99291 Critical Care E&M | Facility | 111 | 39 | $159.23 | $18K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 89 | 59 | $12.19 | $1,085 |
| 93750 External Electrocardiographic Monitoring | Facility | 75 | 20 | $29.40 | $2,205 |
| 99232 Hospital E&M - Subsequent | Facility | 66 | 18 | $58.96 | $3,891 |
| 99233 Hospital E&M - Subsequent | Facility | 45 | 18 | $88.58 | $3,986 |
| 99205 Office E&M - New | Facility | 16 | 16 | $110.57 | $1,769 |
| 99239 Hospital Discharge Management | Facility | 12 | 12 | $85.16 | $1,022 |
| 99214 Office E&M - Established | Facility | 12 | 12 | $70.59 | $847 |
By year: 2022 $61K for 518 services; 2023 $69K for 650 services; 2024 $50K for 611 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jan M Griffin prescribed most often to Medicare patients was Vyndamax (Tafamidis), with 207 prescriptions and refills. In total Jan M Griffin wrote 1,575 Medicare prescriptions that cost $6.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vyndamax Tafamidis | 207 | 243 | 24 | $5.1M |
| Spironolactone Generic | 193 | 338 | 52 | $1,407 |
| Jardiance Empagliflozin | 137 | 191 | 21 | $107K |
| Metoprolol Succinate Generic | 131 | 271 | 32 | $2,129 |
| Entresto Sacubitril/Valsartan | 115 | 168 | 26 | $109K |
| Furosemide Generic | 105 | 186 | 32 | $429 |
| Farxiga Dapagliflozin Propanediol | 98 | 165 | 21 | $92K |
| Losartan Potassium Generic | 86 | 138 | 18 | $917 |
| Eliquis Apixaban | 73 | 138 | 17 | $80K |
| Atorvastatin Calcium Generic | 43 | 107 | 14 | $474 |
| Carvedilol Generic | 39 | 61 | 11 | $318 |
| Bumetanide Generic | 30 | 42 | 14 | $1,022 |
| Rosuvastatin Calcium Generic | 26 | 46 | Under 11 | $452 |
| Eplerenone Generic | 24 | 33 | Under 11 | $1,280 |
| Xarelto Rivaroxaban | 23 | 23 | Under 11 | $12K |
Brand drugs: 705 claims; generic drugs: 870 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jan M Griffin $19K ($19K in general payments such as food, travel and fees) from 5 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $11K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.